MX2018006291A - Composiciones y su uso. - Google Patents

Composiciones y su uso.

Info

Publication number
MX2018006291A
MX2018006291A MX2018006291A MX2018006291A MX2018006291A MX 2018006291 A MX2018006291 A MX 2018006291A MX 2018006291 A MX2018006291 A MX 2018006291A MX 2018006291 A MX2018006291 A MX 2018006291A MX 2018006291 A MX2018006291 A MX 2018006291A
Authority
MX
Mexico
Prior art keywords
potential
subject
cognitive
novo myelination
brain
Prior art date
Application number
MX2018006291A
Other languages
English (en)
Inventor
Schneider Nora
HAUSER Jonas
DEONI Sean
Bartfai Tamas
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018006291A publication Critical patent/MX2018006291A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/38—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1564—Aluminium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1578—Calcium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1588—Copper
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1592—Iron
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/161—Magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1618—Phosphorus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1642—Zinc
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/184—Emulsifier
    • A23V2250/1846—Phosphatidyl Choline
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/184—Emulsifier
    • A23V2250/185—Phosphatidyl Inositol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/184—Emulsifier
    • A23V2250/1852—Phosphatidyl Serine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1862—Arachidonic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1886—Stearic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5424—Dairy protein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/704—Vitamin B
    • A23V2250/7056—Vitamin B8 Folic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/704—Vitamin B
    • A23V2250/706—Vitamin B12

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pediatric Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Biophysics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Psychology (AREA)
  • Social Psychology (AREA)
  • Diabetes (AREA)

Abstract

Una composición nutritiva sintética que comprende una vitamina para usar a fin de promover, apoyar u optimizar la mielinización de novo, particularmente, la trayectoria de mielinización de novo, y/o estructura cerebral, y/o conectividad cerebral, y/o potencial intelectual, y/o potencial cognitivo y/o potencial de aprendizaje, y/o funcionamiento cognitivo en un sujeto, particularmente, en un sujeto alimentado con fórmula.
MX2018006291A 2015-12-14 2016-12-13 Composiciones y su uso. MX2018006291A (es)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
EP15199752 2015-12-14
EP15199758 2015-12-14
EP15199769 2015-12-14
EP15199764 2015-12-14
EP15199757 2015-12-14
US201662315198P 2016-03-30 2016-03-30
US201662315249P 2016-03-30 2016-03-30
US201662315224P 2016-03-30 2016-03-30
US201662315187P 2016-03-30 2016-03-30
US201662315238P 2016-03-30 2016-03-30
US201662328070P 2016-04-27 2016-04-27
PCT/EP2016/080775 WO2017102715A1 (en) 2015-12-14 2016-12-13 Compositions and their use

Publications (1)

Publication Number Publication Date
MX2018006291A true MX2018006291A (es) 2018-08-16

Family

ID=59055879

Family Applications (8)

Application Number Title Priority Date Filing Date
MX2018006292A MX2018006292A (es) 2015-12-14 2016-12-13 Composiciones nutritivas y formula infantil para promover la mielinizacion de novo.
MX2018006298A MX2018006298A (es) 2015-12-14 2016-12-13 Composicion nutritiva y formula infantil para promover la mielinizacion de novo.
MX2018006291A MX2018006291A (es) 2015-12-14 2016-12-13 Composiciones y su uso.
MX2018006295A MX2018006295A (es) 2015-12-14 2016-12-13 Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
MX2023003894A MX2023003894A (es) 2015-12-14 2018-05-21 Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
MX2023009469A MX2023009469A (es) 2015-12-14 2018-05-21 Composicion nutritiva y formula infantil para promover la mielinizacion de novo.
MX2024008971A MX2024008971A (es) 2015-12-14 2018-05-21 Composiciones y su uso.
MX2023003892A MX2023003892A (es) 2015-12-14 2018-05-21 Composiciones nutritivas y formula infantil para promover la mielinizacion de novo.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
MX2018006292A MX2018006292A (es) 2015-12-14 2016-12-13 Composiciones nutritivas y formula infantil para promover la mielinizacion de novo.
MX2018006298A MX2018006298A (es) 2015-12-14 2016-12-13 Composicion nutritiva y formula infantil para promover la mielinizacion de novo.

Family Applications After (5)

Application Number Title Priority Date Filing Date
MX2018006295A MX2018006295A (es) 2015-12-14 2016-12-13 Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
MX2023003894A MX2023003894A (es) 2015-12-14 2018-05-21 Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
MX2023009469A MX2023009469A (es) 2015-12-14 2018-05-21 Composicion nutritiva y formula infantil para promover la mielinizacion de novo.
MX2024008971A MX2024008971A (es) 2015-12-14 2018-05-21 Composiciones y su uso.
MX2023003892A MX2023003892A (es) 2015-12-14 2018-05-21 Composiciones nutritivas y formula infantil para promover la mielinizacion de novo.

Country Status (13)

Country Link
US (8) US11297872B2 (es)
EP (10) EP3389414A1 (es)
CN (5) CN108366606A (es)
AU (13) AU2016374157A1 (es)
BR (8) BR122022001962B1 (es)
ES (1) ES2971165T3 (es)
FI (1) FI3389407T3 (es)
MX (8) MX2018006292A (es)
MY (2) MY197734A (es)
PH (5) PH12018500751A1 (es)
PT (1) PT3389407T (es)
RU (3) RU2766014C2 (es)
WO (5) WO2017102715A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017167417A1 (en) * 2016-03-30 2017-10-05 Nestec S.A. Compositions comprising choline and their use
IL295046B2 (en) 2016-07-06 2024-07-01 Building Block Nutritionals Llc Nutritional formulation
IT201900000043A1 (it) * 2019-01-03 2020-07-03 Watt S R L Sostituto della prima colazione
CN109805390A (zh) * 2019-02-27 2019-05-28 云南大学 一种神经酸钙、神经酸锌及维生素k2复合物软胶囊
CA3158010A1 (en) * 2019-10-29 2021-05-06 Aak Ab (Publ) Nutritional composition comprising milk and egg phospholipids
US11606966B2 (en) 2020-06-15 2023-03-21 Building Block Nutritionals, Llc Nutritional formula
EP4094591A1 (en) * 2021-05-28 2022-11-30 Fonterra Co-Operative Group Limited Food supplement
IT202100022427A1 (it) * 2021-08-27 2023-02-27 Buona S P A Soc Benefit Composizione per la maturazione del sistema nervoso centrale
AU2023327690A1 (en) 2022-08-18 2025-01-16 Société des Produits Nestlé S.A. Kit to promote developmental myelination
WO2024105112A1 (en) * 2022-11-15 2024-05-23 Société des Produits Nestlé S.A. Nutritional composition for improving social-emotional development
EP4449875A1 (en) * 2023-04-18 2024-10-23 Mars, Incorporated Composition for use for improving or preserving mental health in canine

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000057879A1 (en) 1999-03-26 2000-10-05 Barry Reisberg Treatment of brain changes with myelin protective agents
WO2002102394A2 (en) 2001-06-18 2002-12-27 Neptune Technologies & Bioressources Inc. Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
CN1398529A (zh) 2002-09-04 2003-02-26 杭州施惠泰食品化学有限公司 神经酸在母乳化婴幼儿奶粉中的应用
CA2499902C (en) 2002-09-24 2012-01-24 Suntory Limited Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person
NL1021892C2 (nl) 2002-11-11 2004-05-12 Tno Detectie van demyelinisatie.
CN1826060B (zh) * 2003-07-21 2010-06-09 荷兰联合利华有限公司 认知功能的帮助
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
JP4429083B2 (ja) * 2004-06-03 2010-03-10 キヤノン株式会社 遮光型座標入力装置及びその座標入力方法
US20090318394A1 (en) * 2004-11-19 2009-12-24 Julie Nauroth Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same
EP2382872A1 (en) * 2005-04-28 2011-11-02 Enzymotec Ltd. Polar lipid mixtures, their preparation and uses
US20070203235A1 (en) * 2006-02-28 2007-08-30 Rosales Francisco J Method for preventing or treating anemia
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
IL178495A (en) * 2006-10-05 2014-12-31 Univ Ben Gurion Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions
US8178132B2 (en) * 2007-03-22 2012-05-15 Magceutics, Inc. Magnesium-containing food compositions
AU2008312069B2 (en) * 2007-10-19 2014-03-06 Fonterra Co-Operative Group Limited Methods of maintaining or increasing growth or cognitive development
BRPI0818723B1 (pt) * 2007-11-01 2020-02-27 Enzymotec Ltd. Composição para nutrição infantil
EP2229063A1 (en) 2007-12-21 2010-09-22 N.V. Nutricia Use of non-digestible carbohydrates for improving intestinal microbiota
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
CN102131407B (zh) 2008-06-23 2015-01-07 维尔恩公司 含有非极性化合物的组合物
CN101322743A (zh) * 2008-08-01 2008-12-17 李翔 一种能修复眼部病变损伤改善视力疲劳的制剂及其制备方法
EP2258217A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Children
US20120121562A1 (en) 2009-07-31 2012-05-17 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
BR112012005540A2 (pt) * 2009-09-11 2016-04-26 Nestec Sa composições e métodos para melhora da função cognitiva e funções relacionadas em animais
WO2011046451A1 (en) * 2009-10-16 2011-04-21 Fonterra Co-Operative Group Limited Maintaining or increasing cognitive development
CN101861893A (zh) 2010-03-04 2010-10-20 云南大学 神经酸锌在婴幼儿母乳化配方奶粉中的应用
MX348297B (es) * 2010-06-25 2017-06-06 Global Healthcare Focus Llc Métodos de tratamiento de trastornos ópticos.
US8572574B2 (en) * 2010-07-16 2013-10-29 Fujitsu Limited Solving hybrid constraints to validate specification requirements of a software module
EP2452573A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional composition with animal fats and vegetable fats
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2658401A2 (en) 2010-12-31 2013-11-06 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
EP2685963A4 (en) * 2011-03-16 2014-11-19 Signpath Pharma Inc ASSOCIATION OF CURCUMIN WITH TYPE 2 DIABETES ANTIDIABETICS FOR PREVENTING AND TREATING DISEASE SEQUENCES, ADVERSE REACTIONS ASSOCIATED WITH TREATMENT, AND FOR IMPROVING GLYCEMIA CONTROL
CN102240374A (zh) * 2011-06-21 2011-11-16 陈应交 抗健忘少儿益智补脑丸
WO2013138157A1 (en) * 2012-03-14 2013-09-19 Abbott Laboratories Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
US20140199265A1 (en) * 2013-01-11 2014-07-17 Mead Johnson Nutrition Company Nutritional compositions containing a neurologic component and uses thereof
US9301966B2 (en) * 2013-01-11 2016-04-05 Mead Johnson Nutrition Company Nutritional compositions containing magnesium threonate and uses thereof
US20140255537A1 (en) 2013-03-11 2014-09-11 Mead Johnson Nutrition Company Nutritional Compositions Containing an Enriched Lipid Fraction and Uses Thereof
RU2654739C2 (ru) * 2013-04-10 2018-05-22 Нестек С.А. Детская смесь с низким содержанием mcfa в определенных пропорциях и относительно высоким содержанием жирных кислот и ее применение в стимуляции здорового становления когнитивной функции у грудных детей
FR3004649A1 (fr) * 2013-04-18 2014-10-24 Bruno Eto Composition comprenant hydroxocobalamine pour son utilisation dans le traitement par voie orale du deficit en vitamine b12 et les maladies associees
WO2015016285A1 (ja) * 2013-07-30 2015-02-05 Hasegawa Toru 脳機能改善用組成物
US9609888B2 (en) 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
TWI729969B (zh) 2013-08-29 2021-06-11 美商亞培公司 具有改良溶解度及生物可利用性之含有親脂性化合物之營養組合物
CN103610064A (zh) * 2013-12-05 2014-03-05 王丽华 一种益智健脑胶囊及加工方法
MX2016007490A (es) * 2013-12-10 2016-08-19 Nestec Sa Nutricion, ejercicio y desarrollo cognitivo.
EP3079497B1 (en) * 2013-12-12 2019-10-23 Société des Produits Nestlé S.A. Synthetic milk compositions comprising n-6 eicosatrienoic acid and polar lipids for infants younger and older than three months for healthy establishment of cognitive function
US10525016B2 (en) 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
FR3036961B1 (fr) * 2015-06-03 2019-05-24 Densmore Et Cie Complement alimentaire comprenant un melange d'oxyde de magnesium et de carbonate de magnesium
CL2018001598A1 (es) 2015-12-14 2018-10-19 Nestec Sa Composiciones nutricionales y fórmulas infantiles para promover la mielinización en el cerebro
MX2018006293A (es) 2015-12-14 2019-10-21 Soc Des Produits Nestle S A Star Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
CL2018001600A1 (es) 2015-12-14 2018-10-19 Nestec Sa Una composición nutricional sintética que comprende una vitamina para usar a fin de promover, apoyar u optimizar la mielinización de novo
RU2018125702A (ru) 2015-12-14 2020-01-16 Нестек С.А. Питательные композиции и детские смеси для стимуляции миелинизации в головном мозге
MX2018006290A (es) 2015-12-14 2019-02-28 Nestec Sa Composiciones nutritivas y formulas infantiles para promover la mielinizacion en el cerebro.
RU2018125497A (ru) 2015-12-14 2020-01-16 Нестек С.А. Питательные композиции и детские смеси для активирования миелинизации в головном мозге
US11478011B2 (en) 2015-12-14 2022-10-25 Societe Des Produits Nestle S.A. Nutritional compositions and infant formula for promoting de novo myealination
US11986445B2 (en) 2015-12-14 2024-05-21 Societe Des Produits Nestle S.A. Nutritional composition and infant formula for promoting myelination of the brain
CL2018001603A1 (es) 2015-12-14 2018-09-14 Nestec Sa Composición nutricional y fórmula infantil para promover la mielinización de novo
MX2018006296A (es) 2015-12-14 2019-08-21 Nestec Sa Composiciones nutritivas y formulas infantiles para promover la mielinizacion en el cerebro.

Also Published As

Publication number Publication date
EP4233855A3 (en) 2024-01-17
RU2018125738A3 (es) 2020-04-28
MX2024008971A (es) 2024-08-30
PH12018500789A1 (en) 2018-10-29
BR122022002021B1 (pt) 2023-03-14
US11297872B2 (en) 2022-04-12
US20180360789A1 (en) 2018-12-20
AU2021204012B2 (en) 2023-06-01
AU2021204014B2 (en) 2023-06-01
US20220175009A1 (en) 2022-06-09
PH12018500818A1 (en) 2018-10-29
EP3389408A1 (en) 2018-10-24
MX2018006295A (es) 2018-08-16
BR122022001962B1 (pt) 2023-05-16
EP4233904A2 (en) 2023-08-30
BR112018010303B1 (pt) 2022-08-23
AU2016372281A1 (en) 2018-04-19
PH12018500833A1 (en) 2018-10-29
MY197355A (en) 2023-06-14
MX2023009469A (es) 2023-11-01
RU2018125661A (ru) 2020-01-16
RU2018125661A3 (es) 2020-04-28
CN108471796A (zh) 2018-08-31
RU2018125527A3 (es) 2020-04-27
BR112018010632B1 (pt) 2023-01-24
US20180360095A1 (en) 2018-12-20
AU2023219953A1 (en) 2023-09-14
BR112018010265A2 (pt) 2019-01-15
RU2018125738A (ru) 2020-01-16
MY197734A (en) 2023-07-12
US20220378078A1 (en) 2022-12-01
AU2021204027A1 (en) 2021-09-09
WO2017102717A1 (en) 2017-06-22
US20230015563A1 (en) 2023-01-19
MX2023003892A (es) 2023-04-24
AU2021204014A1 (en) 2021-07-08
RU2018125527A (ru) 2020-01-16
AU2016374158A1 (en) 2018-04-19
AU2023214399A1 (en) 2023-08-31
BR112018010265B1 (pt) 2022-08-30
US20190254330A1 (en) 2019-08-22
CN108366606A (zh) 2018-08-03
RU2766014C2 (ru) 2022-02-07
US11191293B2 (en) 2021-12-07
AU2016374160A1 (en) 2018-04-19
CN108366609A (zh) 2018-08-03
MX2018006292A (es) 2018-08-16
EP3389413A1 (en) 2018-10-24
EP4233875A2 (en) 2023-08-30
EP4205561A1 (en) 2023-07-05
EP4233860A3 (en) 2024-01-17
AU2016374155A1 (en) 2018-04-19
BR112018010335A2 (pt) 2018-12-04
EP4233855A2 (en) 2023-08-30
EP4233904A3 (en) 2024-01-10
FI3389407T3 (fi) 2024-01-17
AU2021204020A1 (en) 2021-07-08
CN108463122A (zh) 2018-08-28
MX2023003894A (es) 2023-06-22
AU2016374157A1 (en) 2018-04-19
AU2021204026A1 (en) 2021-09-16
EP4233860A2 (en) 2023-08-30
WO2017102712A1 (en) 2017-06-22
PT3389407T (pt) 2024-01-19
PH12018500752A1 (en) 2018-10-15
WO2017102710A1 (en) 2017-06-22
EP4233875A3 (en) 2023-09-06
WO2017102715A1 (en) 2017-06-22
AU2021204020B2 (en) 2023-05-18
MX2018006298A (es) 2018-11-09
US20220175008A1 (en) 2022-06-09
EP3389414A1 (en) 2018-10-24
BR112018010362A2 (pt) 2018-12-04
US11337449B2 (en) 2022-05-24
EP3389407B1 (en) 2023-11-08
AU2021204027B2 (en) 2023-05-18
WO2017102714A1 (en) 2017-06-22
RU2766598C2 (ru) 2022-03-15
AU2021204012A1 (en) 2021-07-08
CN108495561A (zh) 2018-09-04
PH12018500751A1 (en) 2018-10-15
BR112018010303A2 (pt) 2018-12-04
RU2766208C2 (ru) 2022-02-09
US20240349771A1 (en) 2024-10-24
AU2021204026B2 (en) 2023-06-01
BR122022002030B1 (pt) 2023-05-16
BR112018010362B1 (pt) 2022-08-16
EP3389411A1 (en) 2018-10-24
AU2023219952A1 (en) 2023-09-14
AU2021204020A9 (en) 2021-09-23
US11986003B2 (en) 2024-05-21
BR112018010335B1 (pt) 2022-08-16
EP3389407A1 (en) 2018-10-24
ES2971165T3 (es) 2024-06-03
US11930836B2 (en) 2024-03-19
BR112018010632A2 (pt) 2018-11-27

Similar Documents

Publication Publication Date Title
MX2024008971A (es) Composiciones y su uso.
MX2022012374A (es) Composiciones multi-suplementos.
IL253727A0 (en) Pure cbd and cbda and methods, preparations and products using cbd or cbda
PH12017502255A1 (en) Nrf2 regulators
AU366476S (en) Bottle
BR112016027871A2 (pt) composição para melhorar a memória, a função de aprendizado e/ou função cognitiva
EP3298936A4 (en) GROUP OF STIRRING KNIVES
SG10201803370XA (en) Conjugates of somatostatin and its analogs
MX2022014682A (es) Composiciones y su uso.
MX2022012236A (es) Composiciones que comprenden colina y su uso.
PH12016502311A1 (en) Omega-3 analogues
CL2018001602A1 (es) Composición nutricional y fórmula infantil para promover la mielinización del cerebro
MX2018006293A (es) Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
EP3302093A4 (en) FOOD SUPPLEMENT COMPOSITION FOR ANIMALS
PH12018501029A1 (en) Compositions comprising choline and their use
LV14852A (lv) Triazolilpurīna atvasinājumi kā pretvīrusu preparāti
UA94338U (uk) 2-ОКСО-5-ФЕНІЛ-2,3-ДИГІДРО-ТІАЗОЛО[4,5-b]ПІРИДИН-7-КАРБОНОВА КИСЛОТА, ЩО ПРОЯВЛЯЄ АНТИЕКСУДАТИВНУ ДІЮ
AU5599P (en) NUN 09085 Solanum lycopersicum
SG10201707029YA (en) Enzymatic system-containing cosmetic compositions